Back to search
Scientific Name: Alogliptin
Brand Name: Incresync, Kazano, Nesina, Oseni
Company Owner: Not Available
Mechanism Of Action Alogliptin inhibits dipeptidyl peptidase 4 (DPP-4) , which normally degrades the incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 ( GLP-1) . The inhibition of DPP-4 increases the amount of active plasma incretins which helps with glycemic control. GIP and GLP-1 stimulate glucose dependent secretion of insulin in pancreatic beta cells. GLP-1 has the additional effects of suppressing glucose dependent glucagon secretion, inducing satiety, reducing food intake, and reducing gastric emptying.
Description of the Drug: Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat hyperglycemia in patients with type 2 diabetes mellitus.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from